Human Epidermal Growth Factor Receptor 2 [HER‐2/neu] Amplification and Microsatellite Stable Status in Gastric and Gastroesophageal Adenocarcinoma: Assessing Frequency and Prognostic Implications at the Cancer Institute of Iran
ABSTRACT Background Molecular targeted therapy and immunotherapy have shown promise in managing gastric adenocarcinoma. The amplified expression of Human epidermal growth factor receptor‐2 (HER‐2) and microsatellite stable (MSI) status serve as indicators of response to targeted therapy and immunoth...
Saved in:
| Main Authors: | Samaneh Salarvand, Abbas Mohammadi, Reza Shahsiah, Farzaneh Bagheri, Mahsa Gholizadeh, Somayeh Jolany‐Vangah, Ebrahim Esmati, Marzieh Lashkari, Vahid Soleymani, Seraj Zareh‐Dehabadi, Vahid Mehrtash, Amirmohsen Jalaeefar, Mohammad Shirkhoda, Moones Toosang, Romina Abyaneh, Reza Ghalehtaki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70314 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human umbilical cord mesenchymal stem cells-derived extracellular vesicles as a therapeutic approach to ameliorate bladder injury in animal models of radiation cystitis
by: Parmida Sadat Pezeshki, et al.
Published: (2025-07-01) -
Evaluation of Treatment Response and Survival Outcomes in Anaplastic Thyroid Cancer Patients Following Surgery With and Without Other Treatment Modalities: A Systematic Review
by: Hossein Negahban, et al.
Published: (2025-05-01) -
Surface mold brachytherapy for head and neck non-melanoma skin cancer – local control rates and survival: A retrospective analysis
by: Ebrahim Esmati, et al.
Published: (2024-10-01) -
The role of saliva PCR assay in the diagnosis of COVID-19
by: Alireza Abdollahi, et al.
Published: (2022-01-01) -
Identifying and Preserving Parathyroid Glands During Thyroid Surgery Using Indocyanine Green and a Review of the Literature
by: Maziar Motiee‐Langroudi, et al.
Published: (2025-06-01)